Home › Peripheral T-Cell Lymphoma › Michigan › Ann Arbor
Peripheral T-Cell Lymphoma clinical trials in Ann Arbor, MI
3 studies for Peripheral T-Cell Lymphoma are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Soquelitinib vs Standard of Care in Participants With Relapsed/Refractory Peripheral T-cell Lymphoma Not Otherwise Specified, Follicular Helper T-cell Lymphomas, or Systemic Anaplastic Large-cell Lymphoma
RecruitingPhase 3
- Roger Cancer Center University of Michigan Health, Ann Arbor
A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
RecruitingPhase 1
- University of Michigan, Ann Arbor
Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/Refractory T-cell Non-Hodgkin Lymphoma
RecruitingPhase 1
- University of Michigan, Ann Arbor
Peripheral T-Cell Lymphoma trials in other cities
- Houston, TX9 studies
- New York City, NY6 studies
- Baldwin Park, CA5 studies
- Boston, MA5 studies
- Philadelphia, PA4 studies
- Atlanta, GA3 studies
- Aurora, CO3 studies
- Columbus, OH3 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.